This excerpt taken from the HGSI 10-K filed Feb 28, 2007.
Transgene. In February 1998, we entered into an agreement with Transgene relating to the field of human gene therapy, including gene therapy vaccines, to the extent that it will not conflict with our other collaboration agreements. Under this agreement, we granted Transgene the right to license exclusively up to 10 genes. Our collaboration with Transgene will end in 2008, although royalty rights continue in the event of commercial activity.